• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Transporting Treatment: An Examination of Tubing Technologies

    Outward Appearance: Reviewing Surface Treatment Options

    Face to (Virtual) Face: Telemedicine Now and Post-Pandemic

    Voices for Medtech: AdvaMed and MDMA Leaders Share Thoughts

    Digitize Your QMS via an Enterprise Cloud Platform
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Top News
    Iterative Scopes Announces IBD-Focused Scientific Advisory Board

    Vicarious Surgical, D8 Holdings Corp. Combine Operations in $1.1 Billion Deal

    FDA Grants De Novo Clearance to Medtronic’s GI Genius Model

    Acutus Medical Receives FDA Clearance of AcQCross

    Thermo Fisher Scientific to Acquire PPD for $17.4 Billion
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Transporting Treatment: An Examination of Tubing Technologies

    Outward Appearance: Reviewing Surface Treatment Options

    Face to (Virtual) Face: Telemedicine Now and Post-Pandemic

    Voices for Medtech: AdvaMed and MDMA Leaders Share Thoughts

    Digitize Your QMS via an Enterprise Cloud Platform
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Home Is Where the Heart (Valve) Is

    CGM: Digital Health Meets a Very Large Opportunity

    Biomechanical Engineer, Heal Thyself

    Optimizing MIM in Medical Device Manufacturing

    PPE and Diagnostics: Sourcing Domestically and Speeding Time to Market
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    maxon

    Concise Engineering

    Medbio LLC

    Forefront Medical Technology

    Qosina Corp.
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    Fiber Optics Introducing New Cleanliness Requirements for Medical Electronics

    EMS Providers Valued for Product Customization, Medical Certification Expertise

    Three Future Trends and Opportunities in Quality Assurance

    Adopting a Data-Driven Quality Model

    Digital Transformation for Quality and Manufacturing
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Medicoil

    Trademark Plastics Inc.

    Forefront Medical Technology

    FUTEK Advanced Sensor Technology Inc.

    MW Life Sciences
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • Podcasts
    • Resources
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Columns

    So We’re All on the Same Page: You Need a Test Plan

    ...

    So We’re All on the Same Page: You Need a Test Plan
    Related CONTENT
    • Refurbished Medical Equipment Testing and Certification Under the NEC
    • Pro Tips for Prototypes: The Smart Way to Manage Device Iterations
    • Class III Devices from 10,000 Feet: The Big Picture on Getting Premarket Approval
    • Mock Trial: Outsourcing to Prepare for Your Class III Premarket Panel
    • Peruvian Prospects: The Medical Device Industry of a Country Founded on Precious Metals
    Dawn A. Lissy, Empirical09.01.17
    I’m a huge fan of lists. Covering every base with an organized way to track everything from my companies’ financial progress to whether the Doritos made it into the car for the drive home from school keeps me functioning. I note things on my computer, tablet, smartphone, spiral paper planner, and a series of Post-it notes that wing up around my office like neon butterflies.

    It would never occur to me to not have a test plan. But I frequently find myself explaining the benefits of a plan to clients and dispelling a series of misunderstandings about how a test plan can make the development cycle easier and less expensive. I’ve even had clients who have never heard of such a thing and wonder why anyone would ever craft one.
    I have special list just for them.

    “Less expensive” typically catches everyone’s attention when explaining the benefits of devising a test plan. It varies from client to client, but some have saved as much as 30 percent of overall testing time and financial costs, depending on the type and scope of project. A testing plan solid enough to be the foundation of a successful project yet fluid enough to allow for course corrections eases the path to market—particularly for Class III devices.

    “Easier” is a subjective measurement, however; there’s not necessarily a bottom line or hard number attached to it. But based on what I’ve noticed over the course of my career, it’s better to form a test plan at the beginning of the development cycle. If you wait until mid-cycle, a challenge that could’ve been foreseen might sideline the project and measures must then be put in place to deal with it.

    The Why
    Clients have argued a test plan could limit their options and they don’t want to feel pigeon-holed or wedded to a single path. But after considering the options and plotting the course, identify where and when that plan may need reassessment. The plan will not be carved in stone. Hopefully it won’t manifest in fluorescent paper slips all over the office, but rather a happy medium that allows forward momentum and won’t trap you in a corner.

    Plan Before You Plan
    A failure modes and effects analysis (FMEA) is a risk analysis and starting point. This is a must for Class III devices as well as Class II devices containing a feature with the potential to cause harm, such as an intervertebral body fusion device (IBFD) with a new locking mechanism for expansion purposes. The FMEA will determine any additional testing to consider in order to prove the overall safety and efficacy of the device—benchtop testing, animal testing, or other evaluations needed in the overall test plan. For Class III devices, you’ll also want to consider feasibility testing. Again, this may apply for Class IIs with breakthrough technology applications.

    Now the actual plan is ready to be developed. Feel free to dust off my article “Driving a Successful Medical Device Product Development Cycle” in the July/August 2015 edition of MPO for more details on putting that plan together, but it should include minimum required tests from relevant regulatory agencies, in addition to feasibility or other evaluations identified during the risk analysis.

    More Than Guidance Documents
    Some clients have argued that they don’t need a plan because there are regulatory documents that spell out required tests. While established guidelines and regulatory direction are great fodder for a plan, they’re not an actual process guide for a device. The U.S. Food and Drug Administration’s guidance documents serve as the foundation and minimum requirements, but they’re not a device-specific path to market.

    It’s easy to over- or under-test if those documents aren’t read correctly. Some devices such as vertebral body replacements or cervical or lumbar IBFDs can be tested to up to six different methods per the American Society for Testing and Materials (ASTM) standards. But not every device needs all six tests depending on its indication and location. Only two of six tests have to be performed on a monolithic lumbar device. Knowing the regulatory requirements for the specific kind of device helps to put the best plan in place to use time, money, and testing wisely. With Class III devices, there may not be a standard to test a device to, thereby requiring a test plan to propose to the regulatory agency.

    I’ve actually had face-palm moments when a client informs me they performed all six tests when they only needed four. They covered their bases mid-process because they didn’t have a plan, which cost them time and money they didn’t need to spend.

    Let’s also consider who you’re working with. The regulatory community is full of planners. Anyone who reports to a governmental agency—regardless of what country it’s in—has a series of boxes to check. It will be easier on everyone if a document to share with reviewers at any point in the cycle is available.

    Putting It in Writing
    When developing a test plan, you’re making a map—creating a document that will enable the entire team to literally be on the same page. This is where you’re doing homework and will see potential liabilities as well as possible shortcuts. Once this critical baseline is obtained, a realistic timeline and the bookends of possibilities can be developed. Best-case to worse-case scenarios and where/when those issues can pop up will be known.

    With this outline of major deadlines and turning points, you’ll be able to allocate resources and refine schedules to smooth the journey.

    Everyone will have the deadlines, everyone will get the same information, and the whole team will work off the same document. Given the number and variety of people that must work together to get a medical device to market—regulatory, manufacturing, production development, surgeons, etc.—this is essential. If everyone understands what the steps are and that those steps can’t be skipped, precious time will not be wasted. It’s ultimately about setting and managing stakeholder expectations.

    Bringing the Future to the Present
    Alan Lakein, author of “How to Get Control of Your Time and Your Life,” sums it up nicely: “Planning is bringing the future into the present so you can do something about it now.”
    Consider the future of the device, the team, and your goals. Then bring all of that into the present with a test plan that will move the endeavor forward to meet those goals. 


    Dawn Lissy is a biomedical engineer, entrepreneur, and innovator. Since 1998, the Empirical family of companies (Empirical Testing Corp., Empirical Consulting, LLC, and Empirical Machine, LLC) has operated under Lissy’s direction. Empirical offers the full range of regulatory and quality systems consulting, testing, small batch and prototype manufacturing, and validations services to bring a medical device to market. Empirical is very active within standards development organization ASTM International and has one of the widest scopes of test methods of any accredited independent lab in the United States. Because Lissy was a member of the U.S. Food and Drug Administration’s Entrepreneur-in-Residence program, she has first-hand, in-depth knowledge of the regulatory landscape. Lissy holds an inventor patent for the Stackable Cage System for corpectomy and vertebrectomy. Her M.S. in biomedical engineering is from The University of Akron, Ohio.
    Related Searches
    • test
    • regulatory
    • body
    • it
    Related Knowledge Center
    • Testing
    Suggested For You
    Refurbished Medical Equipment Testing and Certification Under the NEC Refurbished Medical Equipment Testing and Certification Under the NEC
    Pro Tips for Prototypes: The Smart Way to Manage Device Iterations Pro Tips for Prototypes: The Smart Way to Manage Device Iterations
    Class III Devices from 10,000 Feet: The Big Picture on Getting Premarket Approval Class III Devices from 10,000 Feet: The Big Picture on Getting Premarket Approval
    Mock Trial: Outsourcing to Prepare for Your Class III Premarket Panel Mock Trial: Outsourcing to Prepare for Your Class III Premarket Panel
    Peruvian Prospects:  The Medical Device Industry of a Country Founded on Precious Metals Peruvian Prospects: The Medical Device Industry of a Country Founded on Precious Metals
    Testing…Testing…Is This Thing On? Should You Outsource Device Testing or Keep it In-House? Testing…Testing…Is This Thing On? Should You Outsource Device Testing or Keep it In-House?

    Related Columns

    • Testing
      The Evolution of Chemical Characterization for Medical Devices

      The Evolution of Chemical Characterization for Medical Devices

      Evaluation of biological safety of devices is experiencing some of the most significant changes in history.
      Sandi Schaible, Senior Director, Analytical Chemistry and Regulatory Toxicology, WuXi AppTec Medical Device Testing 04.01.21

    • Testing
      Going Beyond the Regulations to Evaluate Relevant Medical Device Risk

      Going Beyond the Regulations to Evaluate Relevant Medical Device Risk

      Companies need to review their testing plan so it supports a successful submission, saves time, and ensures the long-term success of their product.
      Sherry Parker, Ph.D., Senior Director of Regulatory Toxicology, WuXi AppTec Medical Device Testing 06.04.20

    • Testing
      The Importance of Usability/Human Factors Testing

      The Importance of Usability/Human Factors Testing

      When is the work of human factors over, and how does your team know they are prepared for summative testing?
      Maria Shepherd, President and Founder, Medi-Vantage 03.04.20


    • Materials | Testing
      Particle Particulars: Why this Analysis Is Foundational for Successful Devices

      Particle Particulars: Why this Analysis Is Foundational for Successful Devices

      In the mid-2000s, medical device experts were hopeful they’d found one solution to longer-lasting implants.
      Dawn A. Lissy, President & Founder, Empirical 03.04.20

    • R&D & Design | Testing
      FDA Guidelines for Employing X-ray Inspection in Medical Device Development

      FDA Guidelines for Employing X-ray Inspection in Medical Device Development

      Different materials exhibit different radiopacity as a function of material composition (i.e. atomic weight) and thickness.
      Gil Zweig, President, Glenbrook Technologies 01.29.20

    • Testing
      Managing Risks for Medical Devices:  A Guide to Understanding ISO 14971

      Managing Risks for Medical Devices: A Guide to Understanding ISO 14971

      The intent of ISO 14971 is to provide a general “bird’s-eye view” approach to designing and implementing a risk management plan for medical devices.
      Helin Räägel, Ph.D., Biocompatibility Expert, Nelson Labs 10.08.19


    • Testing
      Preparing for MDR: Test In-House or Outsource?

      Preparing for MDR: Test In-House or Outsource?

      As the EU MDR deadline draws near, manufacturers are under pressure to bring products into compliance and get submissions in front of regulators ASAP.
      Sandi Schaible, Senior Director, Analytical Chemistry and Regulatory Toxicology, WuXi Medical Device Testing 10.08.19

    • Testing
      Why Big Companies With Internal Labs Should Outsource Testing

      Why Big Companies With Internal Labs Should Outsource Testing

      ...
      Dawn A. Lissy, President & Founder, Empirical 03.07.19

    • Packaging & Sterilization | Testing
      Coming Clean: Developing Standards for Cleaning Reusable Devices and Instruments

      Coming Clean: Developing Standards for Cleaning Reusable Devices and Instruments

      ...
      Dawn A. Lissy, President & Founder, Empirical 07.26.18


    • 3D/Additive Manufacturing | Testing
      The Final Four: My Top Headlines for 2017

      The Final Four: My Top Headlines for 2017

      ...
      Dawn A. Lissy, President & Founder, Empirical 11.07.17

    • Packaging & Sterilization | Testing
      Packaging Validations—Looking Beyond ISO 11607

      Packaging Validations—Looking Beyond ISO 11607

      ...
      Christopher Scott, Vice President, Eurofins Medical Device Testing 10.05.17

    • 3D/Additive Manufacturing | R&D & Design | Testing
      Pro Tips for Prototypes: The Smart Way to Manage Device Iterations

      Pro Tips for Prototypes: The Smart Way to Manage Device Iterations

      ...
      Dawn A. Lissy, Empirical 07.26.17


    • Digital Health | Software & IT | Testing
      Recent Cyber Attack Enough to Make Medtech WannaCry

      Recent Cyber Attack Enough to Make Medtech WannaCry

      ...
      Michael Barbella, Managing Editor 06.06.17

    • R&D & Design | Testing
      The Human Factor

      The Human Factor

      ...
      Steve Maylish and Dave Hines, Fusion Biotec 05.01.17

    • Testing
      Peruvian Prospects:  The Medical Device Industry of a Country Founded on Precious Metals

      Peruvian Prospects: The Medical Device Industry of a Country Founded on Precious Metals

      ...
      Dawn A. Lissy, President & Founder, Empirical 04.03.17


    Trending
    • Portable, Home-Use Device Quickly Measures Inflammation Levels
    • Survey: Remote Patient Monitoring To Match Or Surpass In-Patient Within Five Years
    • Face Mask Filters 98 Percent Of COVID-19 Particles
    • Thermo Fisher Scientific To Acquire PPD For $17.4 Billion
    • Top 10 Trends In The Medical Device And Equipment Industry
    Breaking News
    • Iterative Scopes Announces IBD-Focused Scientific Advisory Board
    • Vicarious Surgical, D8 Holdings Corp. Combine Operations in $1.1 Billion Deal
    • FDA Grants De Novo Clearance to Medtronic’s GI Genius Model
    • Acutus Medical Receives FDA Clearance of AcQCross
    • Thermo Fisher Scientific to Acquire PPD for $17.4 Billion
    View Breaking News >
    CURRENT ISSUE

    April 2021

    • Transporting Treatment: An Examination of Tubing Technologies
    • Face to (Virtual) Face: Telemedicine Now and Post-Pandemic
    • Outward Appearance: Reviewing Surface Treatment Options
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    AstaReal Astaxanthin Ingredient Receives U.S. Patent Approval
    Study on Kemin’s DailyZz Botanical Blend Uncovers Sleep Quality, Next-Day Performance Benefits
    FDA’s Dr. Cara Welch Opening Speaker at the 9th AHPA Botanical Congress
    Coatings World

    Latest Breaking News From Coatings World

    Jebsen & Jessen, Innospec Sign Distribution Agreement
    IGL Coatings Announces Partnership in Finland
    Axalta Schedules 1Q 2021 Earnings Conference Call
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Iterative Scopes Announces IBD-Focused Scientific Advisory Board
    Vicarious Surgical, D8 Holdings Corp. Combine Operations in $1.1 Billion Deal
    FDA Grants De Novo Clearance to Medtronic’s GI Genius Model
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Bristol Myers Squibb Expands at Cambridge Crossing
    Amgen Completes Five Prime Acquisition
    Sartorius Expands in the UK
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Former L’Oréal Exec Joins Glossier
    Lancôme Reveals New Global Sustainability Program
    First-Ever Skincare Line Focuses on Iron To Prevent Aging
    Happi

    Latest Breaking News From Happi

    Fragrance Creators Association Celebrates P&G Executive
    What You're Reading on Happi.com
    Former L’Oréal Exec Joins Glossier
    Ink World

    Latest Breaking News From Ink World

    Kumon North America Adds Speedmaster XL 106 from Heidelberg
    SE-DA Invests in Kornit Presto S
    Acrylic Resins Market Worth $21.9 Billion by 2025: MarketsandMarkets
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    TLMI reveals Eugene Singer Award winners at Virtual Spring Summit
    Monadnock Paper Mills joins SGP
    ACTEGA helps converter reach sustainability goals
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Albaad to Add Natural-Based Line in Israel
    First Quality to Discontinue Tampon Operations
    Jessup Installs New Era Coating and Laminating Line
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    BioMagnetic Sciences Names President and CEO
    Mainstay Medical Launches ReActiv8 in Australia
    Biogennix Rolls Out Agilon Strip Bone Graft
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Virtual ASMC 2021 Spotlights Advanced Semiconductor Manufacturing Excellence
    LG Display Cuts Down CO2-eq Emissions by 3 Million Tons in 2020
    European Commission's Innovation Radar Acknowledges 3 ARMOR Innovations

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login